PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092734
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2092734
Artificial Joints Market size was valued at US$ 28,605.1 Million in 2025, expanding at a CAGR of 6.6% from 2026 to 2033.
The artificial joints market covers devices that replace hips, knees, shoulders and elbows. This is one of the stable parts of orthopedic medicine. Demand is largely driven by an aging population, rising arthritis cases, and a growing number of injury-related replacements, particularly among older and increasingly active adults. Companies that make these devices are working to improve them by using better materials and enhancing the surgical techniques, such as utilizing robots to assist with the operation. This helps the devices last longer. Overall, the market is well established but still growing, supported by consistent clinical demand and ongoing product innovation.
Artificial Joints Market- Market Dynamics
Rising Prevalence of Osteoarthritis and an Aging Population to Drive Market Growth
The rising global prevalence of osteoarthritis is a major factor driving demand for artificial joints. According to the World Health Organization, osteoarthritis affected approximately 607 million people worldwide in 2021, representing around 7.7% of the global population, compared with 4.8% in 1990. Knee osteoarthritis accounts for nearly 56% of all osteoarthritis cases, making it the most common indication for joint replacement procedures. Furthermore, the World Health Organization projects that the global population aged 60 years and older will reach 2.1 billion by 2050, while the number of individuals aged 80 years and above is expected to increase to 426 million. Combined with the growing prevalence of obesity and longer life expectancy, these demographic trends are expected to substantially increase the incidence of degenerative joint diseases. As a result, the demand for artificial joints is anticipated to witness sustained long-term growth, supported by the increasing need for hip, knee, and other joint replacement procedures worldwide.
The Global Artificial Joints Market is segmented on the basis of Type, Material, Site Outlook, Age Group, End User, and Region.
The artificial joints market is segmented by type into cemented and non-cemented joints. Cemented joints provide immediate implant fixation using polymethyl methacrylate (PMMA) bone cement, making them suitable for patients with lower bone density. In contrast, non-cemented joints are increasingly preferred due to their ability to promote biological bone ingrowth, offering enhanced long-term stability and improved outcomes in younger and more active patients.
Based on material, the market comprises Metal-on-Metal (MoM), Metal-on-Polyethylene (MoP), Ceramic-on-Ceramic (CoC), Ceramic-on-Polyethylene (CoP), and Polyethylene-on-Polyethylene (PoP) bearing surfaces. Advancements in alloy, ceramic, and polyethylene technologies are improving implant durability, wear resistance, and biocompatibility, supporting the growing adoption of advanced artificial joint materials.
Artificial Joints Market- Geographical Insights
North America is the leading market making up over 35% of global revenue. This is because it has a developed healthcare system, many people with osteoarthritis and a strong use of new technologies like robotic surgery. The United States is a part of this with top manufacturers and good research. The region performs well financially because of supportive policies and high-priced implants. However, the high cost of procedures which can range from $30,000 to $50,000 for a hip replacement limits growth.
Europe comes in second with around 25% of the market. It is a market that is growing steadily. Europe is expected to keep growing at a rate of about 9.3% each year until 2035. This growth is supported by replacement needs and more people accepting minimally invasive surgeries. The growth in countries like Germany, the UK, France and Italy are mainly due to an aging population.
The artificial joint market is very competitive. The main companies are trying to be different from each other by making products improving the way these products are fixed in the body using better materials and using robots to help with surgery. Some of these companies are also buying companies to get more products and move into new areas of medicine. The big companies in this market like Zimmer Biomet, Stryker, Johnson & Johnson, Smith & Nephew and Medacta International are still the leaders. continue to consolidate their positions through a combination of product pipeline expansion, strategic partnerships, and targeted acquisitions aimed at strengthening their competition.
Medacta International is an example of this. Through 2025, the company continued to advance its NextAR platform, a mixed-reality surgical navigation system that uses wearable visualization technology to provide surgeons with real-time intraoperative guidance, reinforcing the broader industry shift toward digitally enabled, precision-driven joint replacement procedures. The combined effect of platform innovation and inorganic growth has positioned Medacta as an increasingly formidable competitor within the global artificial joint market.
In the year 2025 the company Exactech, Inc. Made some changes. The new company that bought some of Exactech, Inc. Assets is called Advita Ortho. This company now owns the portfolio of Exactech, Inc. Which includes the Exactech, Inc. Products like the Equinoxes Shoulder and the Truliant Knee and the Alteon Hip and the Vantage Ankle lines. The new company Advita Ortho is now, in charge of these Exactech, Inc. Products.
In 2025, Stryker expanded its Mako SmartRobotics platform by introducing additional software enhancements and implant compatibility for hip and knee replacement procedures.